News

Physician, educate thyself (online)

UofL website now offers Continuing Medical Education credit
Physician, educate thyself (online)

This screenshot shows the opening of “Analyzing the Accuracy of Cardiac Risk Calculators with Dr. DeFilippis,” one of 17 new CME-accredited video lectures available on LouisvilleLectures.org.

A free, open access medical education website launched by the University of Louisville Department of Medicine last year has added Continuing Medical Education (CME) credit for some video lectures it offers. Annual CME is required for physicians to maintain their licensure.

LouisvilleLectures.org has launched 17 lectures that provide CME credit, said chief resident Michael Burk, M.D., founder and managing director of the site. The Office of Continuing Medical Education and Professional Development at the UofL School of Medicine certifies the lectures so that they meet national and state requirements.

“We’ve worked with faculty from throughout the UofL School of Medicine to bring a variety of CME-accredited lectures online,” Burk said. “We will continue to add more CME-accredited lectures as time goes on.”

The 17 CME-accredited lectures are:

  • Acute and Chronic Diarrhea
  • Acute Kidney Injury
  • Acute Pancreatitis
  • Adrenal Disorders
  • Allergic Rhinitis
  • Anemia
  • Antibiotics Review I
  • Aortic Stenosis/Valvular Principles
  • Bradyarrhythmias
  • Calcium Homeostasis
  • Cardiovascular Risk Predictors
  • C. Difficile
  • Electrolyte Emergencies
  • Emergency Arrhythmias 101
  • Internist's Approach to Gastrointestinal Cancers
  • Pneumonia in Many Forms
  • Sodium, Potassium and Diuretics
  • The lectures are available in four formats: online at LouisvilleLectures.org; on YouTube; via iTunes podcast; and via Android podcast.

    As with the 100 lectures currently available from LouisvilleLectures.org, the 17 CME-accredited lectures are provided to the general public free of charge. After viewing a CME-accredited lecture, physicians can click the “claim your CME credit” link to register their completion and obtain the credit. Each CME-accredited lecture hour is $9.99, payable online.

    While never intended to replace traditional residency education, LouisvilleLectures.org augments the availability and accessibility of medical education, Burk said.

    “We want to give providers a reliable source of online CME-accredited programs that they can view at their convenience,” Burk said. “The online format also enables us to update content more rapidly than in a traditional didactic lecture presentation, helping providers stay abreast of the latest advances in medical care.”

    UofL medical student earns top award for financial planning tool for young physicians

    Michael Lovelace recognized by AAFP Foundation for leadership project
    UofL medical student earns top award for financial planning tool for young physicians

    Michael Lovelace, M.B.A., M.S. 4

    A pivotal point for young physicians comes just after medical school as they begin residency. They are earning a paycheck for perhaps the first time, yet also may face significant educational debt and a host of decisions that have the potential to derail their financial situation for years to come. Michael Lovelace, M.B.A., a fourth-year student at the University of Louisville School of Medicine, has developed an award-winning digital tool to help these young physicians make sound financial decisions.

    Lovelace, who studied finance and business prior to entering medical school, developed the tool as part of the Family Medicine Leads (FML) Emerging Leader Institute, sponsored by the American Academy of Family Physicians (AAFP) Foundation. Lovelace, one of 30 participants selected for the first cohort of the year-long program, participated in the group’s leadership workshop last summer, then worked with a physician mentor to create a project in Personal and Practice Leadership, one of three leadership tracks available to the scholars. The other tracks were Policy and Public Health Leadership and Philanthropic and Mission-Driven Leadership. Judges selected Lovelace’s project as the best project in the Personal and Practice Leadership track.

    Lovelace tapped into hisbusiness experience to create the detailed financial planning and budgeting tool. He explained that although physicians beginning residency may qualify to purchase expensive cars and higher priced homes based on future income potential, it’s dangerous to make these purchase decisions without careful analysis of the whole financial picture – including medical education debt that may exceed $175,000.

    “Often people will buy a car and sign an apartment lease as independent decisions and not consider how much of their monthly income they are committing to those two items. Those are binding agreements, so you can make two relatively straightforward decisions and put yourself in a bind throughout residency,” Lovelace said.

    Lovelace’s budget program uses answers to 35 questions related to the user’s financial obligations to calculate their financial trajectory, including a detailed analysis for multiple student loan repayment options and a retirement savings projection. It then generates a report revealing areas of budget concern (too high or too low) and whether the user is projected to reach a retirement goal. It even provides suggestions of how to correct an underfunded retirement plan.

    As part of the project submission, Lovelace created a video description of the budgeting tool and a poster describing the problem and how the analysis can help individuals avoid common pitfalls.He said his project mentor, Marc Matthews, M.D., a family practitioner with the Mayo Clinic, encouraged him to increase the functionality of each module, adding value for the user, while keeping the project within the original scope.

    Jason Marker, M.D., M.P.A., past president of the AAFP Foundation who chairs the foundation workgroup that launched the FML Emerging Leader Institute, said Lovelace’s project exemplifies the leadership potential of the students and residents participating in the institute.

    “One of our hopes with the FML Emerging Leader Institute was that we would take a group of scholars, many of whom had little formal family medicine leadership training, and accelerate their capacity and motivation toward being physicians with the understanding to practice medicine in the context of social determinants of health, elimination of health disparities and avoiding future physician burnout,” Marker said. “In that latter category, Michael's project is a standout. As Michael is lecturing on this topic, I know he will help a lot of young physicians be successful.”

    Stephen Wheeler, M.D., associate dean for admissions at the UofL School of Medicine and a senior faculty member in the Department of Family and Geriatric Medicine, has mentored Lovelace in family medicine and leadership at UofL.

    I first met Michael during his path toward medicine as a non-traditional applicant. Then, I worked with him during the two-year introduction to clinical cases small group experience. I am ecstatic that he feels called in this direction. He will be an exceptional family doctor,” Wheeler said.

    At last summer’s leadership workshop, Marker led a session on Personal and Practice Leadership with Lovelace and the other FML Emerging Leader Institute participants.

    ”We talked about financial realities of practice and how ill-prepared many medical students and residents are for life beyond residency. The way Michael addressed this topic is excellent. He has made the information accessible for the broadest possible audience,” Marker said, adding that he hopes the project will ultimately be adapted for use by medical schools and residency programs to help physicians avoid financial missteps.

    As the creator of the top project in his track, Lovelace will give an oral presentation of the project at the American Academy of Family Physicians National Conference of Family Medicine Residents and Medical Students on July 28 in Kansas City and attend Family Medicine Experience, the annual educational meeting of the AAFP to be held in Orlando in September.

     

    About theAmerican Academy of Family Physicians Foundation

    The AAFP Foundation serves as the philanthropic arm of the American Academy of Family Physicians. Its mission is to advance the values of family medicine by promoting humanitarian, educational and scientific initiatives that improve the health of all people.

     

    July 11, 2016

    Daughter of UofL faculty member up for Espy Award

    Cast your vote online through July 13
    Daughter of UofL faculty member up for Espy Award

    Oksana Masters on the medal stand at the Sochi Olympics in 2014

    For the third year in a row, Oksana Masters is one of four nominees for ESPN’s Female Athlete With A Disability Award. The Louisvillian — daughter of UofL Assistant Professor M. Gay Masters, Ph.D., in the Department of Otolaryngology-Head and Neck Surgery and Communicative Disorders — is nominated for her prowess in cross-country skiing.

    Winners of the annual Espy Awards are selected through online fan balloting conducted from among candidates selected by the ESPY Select Nominating Committee. The public can vote online now until 5 p.m. EDT, July 13, on the ESPN website.

    “I'm thrilled to see Oksana recognized for her talent and incredible hard work as an athlete. The ESPY nomination itself is already a win,” Gay Masters said. “We both appreciate your votes and support.”

    Born in the Ukraine in 1989, Oksana Masters was brought to the United States by her adoptive mother when she was seven. She was born with several radiation-induced birth defects,including tibial hemimelia (resulting in different leg lengths), missing weight-bearing shinbones in her calves, webbed fingers with no thumbs, and six toes on each foot.

    After moving to the United States in 1997, both of Oksana's legs were eventually amputated above the knee —her left leg at age eight and her right leg at age 13 — as they became increasingly painful and unable to support her weight. Oksana also had surgery to modify her innermost fingers on each hand so they could function as thumbs.

    Oksana first made a name for herself as she won a bronze medal in rowing with partner Rob Jones at the London 2012 Paralympic Games, the first-ever United States medal in trunk and arms mixed double sculls with a final time of 4:05.56. She then transitioned her talents to the snow and won silver and bronze at the 2014 Sochi Paralympic Winter Games in cross-country skiing.

    When issues with her back prevented her return to the water for the 2016 Summer Games, Masters decided to give the sport of cycling a try. She has qualified for the 2016 Summer Paralympic Games in Rio de Janeiro, Sept. 7-18, in paracycling, her fourth competitive sport.

    Espy winners will be announced in the Espy Awards telecast at 8 p.m. EDT, July 13, on ABC-TV hosted by WWE wrestler John Cena. For more information, go to the Espy Awards website.

    UofL neurosurgeon leads clinical trial to test therapy for brain hemorrhage

    Robert F. James, M.D., leading national phase II trial investigating low-dose heparin treatment following ruptured brain aneurysm
    UofL neurosurgeon leads clinical trial to test therapy for brain hemorrhage

    Robert F. James, M.D.

    A Louisville patient is the first to be enrolled in a national clinical trial to test a new treatment for patients who have suffered a ruptured brain aneurysm. The trial, based at the University of Louisville under principal investigator Robert F. James, M.D., associate professor in the Department of Neurosurgery at UofL, will include eight other medical centers in the United States.

    James, chief of neurosurgery at University of Louisville Hospital, part of KentuckyOne Health, and chief of the Division of Cerebrovascular and Endovascular Neurosurgery at UofL, is leading the ASTROH study, a phase II, randomized clinical trial to determine whether a continuous 14-day, low-dose intravenous infusion of heparin is safe and effective in patients with ruptured brain aneurysms.

    “We believe this treatment may help prevent the long-term delayed neurological deficits (DNDs) and cognitive dysfunction that often afflict patients who survive the initial aneurysm rupture,” James said.

    A brain aneurysm is a balloon-like bulge that forms when a segment of a blood vessel in the brain weakens and swells. If the aneurysm bursts, blood is leaked into the area between the brain and the thin tissues covering the brain known as the subarachnoid space. This condition is known as subarachnoid hemorrhage (SAH). Patients who survive the initial hemorrhage are at high risk for delayed secondary brain injury, resulting in problems with localized neurological functions such as speech, vision, hearing or individual areas of the body, and long-term cognitive and psychosocial deficits. These problems are referred to as SAH-induced delayed neurological deficits (DNDs).

    The ASTROH study will examine whether the use of intravenous heparin for 14 days following the repair of the ruptured aneurysm will control neuro-inflammation and improve clinical outcomes. Patients who enter University of Louisville Hospital or one of the other participating medical centers having experienced a ruptured brain aneurysm may be evaluated for participation in the trial.

    ASTROH, which stands for “Aneurysmal Subarachnoid Hemorrhage Trial RandOmizing Heparin,” will involve up to 88 patients at the nine medical centers over a period of two years. James is working with co-investigators at the University of Maryland, Yale University and Icahn School of Medicine at Mount Sinai. The trial is funded by the UofL Department of Neurosurgery through the UofL Research Foundation, Penumbra, Inc., MicroVention, Inc., and the Brain Aneurysm Foundation.

    UofL Human Subjects Protection Program earns reaccreditation

    Participants in clinical trials are assured of professionalism, ethical standards
    UofL Human Subjects Protection Program earns reaccreditation

    Dr. Ken Lucas, right, checks Sam Rosebrock of Morganton, N.C., at UofL's Kosair Charities Pediatric Clinical Research Unit. The UofL office overseeing patients in research trials like Sam has earned reaccreditation for the next five years.

    Research involving human subjects at the University of Louisville continues to follow the most stringent ethical and professional guidelines in existence, as evidenced by the UofL Human Subjects Protection Program earning reaccreditation by the Association for the Accreditation of Human Research Protection Programs.

    The UofL Human Subjects Protection Program Office (HSPPO) was awarded full accreditation for the maximum period allowed, five years. The HSPPO was the first such program in Kentucky accredited by the association when it received its original accreditation in 2005.

    “Accreditation by the Association for the Accreditation of Human Research Protection Programs means that people who volunteer to participate in research studies are assured that the highest standards of professionalism are maintained,” William M. Pierce Jr., Ph.D., executive vice president for research and innovation, said.

    “We are proud of our staff in each of our research programs who work diligently to protect participants in research studies and maintain compliance with all regulations that govern research involving human subjects.”

    An independent, non-profit accrediting body, the Association for the Accreditation of Human Research Protection programs (AAHRPP) uses a voluntary, peer-driven, educational model to ensure that facilities conducting research with human participants meet rigorous standards for quality and protection. To earn accreditation, organizations must provide tangible evidence—through policies, procedures, and practices—of their commitment to scientifically and ethically sound research and to continuous improvement.

    More than 60 percent of U.S. research-intensive universities and 65 percent of U.S. medical schools are either AAHRPP accredited or have begun the accreditation process. Sponsors and other funders recognize that AAHRPP-accredited organizations have more efficient operations, provide more comprehensive protections and produce high-quality data.

    At UofL, the Human Subjects Protection Program Office helps to ensure that research involving human participants is conducted in accordance with federal and state regulations and university and sponsoring agency policies and procedures instituted to protect the rights and welfare of human research participants.

    HSPPO upholds this commitment to the protection of human participants involved in research regardless of the funding source and regardless of the location of the research. HSPPO supports two established and independent Institutional Review Boards (IRB), which review and approve protocols for all research involving human participants, the Social/Behavioral/Educational IRB on UofL’s Belknap campus and the Biomedical IRB on the Health Sciences Center campus.

    Knights Templar Eye Foundation, Inc., grant supports UofL research for improved retinoblastoma treatment

    Nanoparticle encapsulation for melphalan may reduce number of chemotherapy treatments in children with eye cancer
    Knights Templar Eye Foundation, Inc., grant supports UofL research for improved retinoblastoma treatment

    Knights Templar of Kentucky presentation to UofL researchers

    UofL researchers Aparna Ramasubramanian, M.D., and Jill Steinbach-Rankins, Ph.D., have received a grant from the Knights Templar Eye Foundation, Inc., to support their work in developing an improved chemotherapy treatment for retinoblastoma. Ramasubramanian, a pediatric ophthalmologist and ocular oncologist, and Steinbach-Rankins, a professor of bioengineering at the UofL J.B. Speed School of Engineering, are developing nanoparticles that will encapsulate the drug melphalan for use in intravitreal injections in the treatment of retinoblastoma.

    Retinoblastoma is the most common type of eye cancer in children. Each year, approximately 300 children, usually under the age of 5, are diagnosed with retinoblastoma in the United States. The cancer begins in the retina, the layer of nerve tissue lining the inside of the back of the eye.

    Melphalan is the most commonly used chemotherapy drug for intraocular injection in retinoblastoma. It is delivered into the vitreous cavity of the eye with the patient under general anesthesia. Since the drug degrades quickly, four to 12 injections may be required to control the tumor. Injection into an eye with an active tumor poses the risk of allowing the cancer to spread to other areas of the body, and with repeated injections, toxicity in the retina and the rate of complications increases.

    Ramasubramanian and Steinbach-Rankins are developing a method for encapsulating melphalan using nanoparticles that will allow the medication to remain viable longer, reducing the number of injections needed and thereby minimizing the side effects and need for anesthesia.

    “Typically the treatment requires six to eight injections. If we can reduce that number by even half, it would greatly reduce the risks associated with the treatment,” said Ramasubramanian, who specializes in the treatment of eye cancers.

    They hope to have a version of the medication available for clinical trials within two years.

    "Blindness from ocular retinoblastoma is a tragic occurrence but new treatments can prevent loss of vision and loss of life. Unfortunately, treatment can sometimes have significant adverse effects throughout the body,” said Henry Kaplan, M.D., chair of the UofL Department of Ophthalmology and Visual Sciences. “The ability to deliver effective anti-tumor medications in small particles (nanoparticles) directly into the eye should avoid this problem and allow a much easier treatment course for patients."

    The Knights Templar Eye Foundation, Inc., incorporated in 1956, is a charity sponsored by the Grand Encampment of Knights Templar based in Flower Mound, Texas. Since 2010, the organization’s mission has been to improve vision through research, education, and supporting access to care.

    “The Knights Templar Eye Foundation offers grants of $65,000 to researchers who are doing work in the field of eye research,” said Larry Carte, the deputy grand commander of the Knights Templar of Kentucky who presented the check on June 24. “The work Dr. Ramasubramanian is doing here is very important and they are pleased to offer her the grant to support her research.”

    Ramasubramanian will have the option to apply for an additional grant next year if the project is not complete. The Knights Templar Eye Foundation has awarded research grants totaling more than $23 million to researchers working in the fields of pediatric ophthalmology and ophthalmic genetics.

    Precision medicine for brain tumors to be discussed at UofL

    July 8 symposium speakers include contributor to new tumor classifications and other world renowned researchers
    Precision medicine for brain tumors to be discussed at UofL

    Kosair Charities Clinical and Translational Research Building

    A new classification system for tumors of the brain and spinal cord released this year by the World Health Organization will help physicians tailor treatments more precisely to a patient’s tumor. Kenneth Aldape, M.D., who helped develop the new classification system, will discuss its significance July 8 at the University of Louisville’s second annual James Graham Brown Cancer Center Neuro-oncology Symposium in his discussion, “Molecular Markers for Adult Glioma.” Gliomas are tumors that develop in the supportive tissue of the brain.

    Aldape was part of an international team of medical researchers contributing to the 2016 World Health Organization Classification of Tumors of the Central Nervous System (2016 WHO CNS), which sets the international standard for describing and classifying tumors of the central nervous system. The 2016 edition provides universal terminology allowing physicians and researchers to define tumors based not only on their morphology (the form and structure of the tumors), but also on their molecular characteristics (genetic mutations or structural variants). These standards ultimately will facilitate more precise and effective treatments for patients.

    “These new classifications position us on the path of delivering precision medicine,” said Eyas Hattab, M.D., M.B.A., chair of the UofL Department of Pathology and Laboratory Medicine. “This will allow physicians to tailor treatments more specifically to the individual patient’s tumor.”

    For example, prior to the 2016 CNS WHO, a tumor may have been identified as glioblastoma based on its location and cell structure. The revised classification now provides universal terminology to identify the tumor as either IDH-mutant or IDH-wildtype, based on molecular characteristics. This refinement will allow for more accurate prognosis for patients and the potential development of specific treatments for different tumors.

    “If we know these are molecularly distinct entities, it gives us the opportunity to study their behaviors. We can come back in a few years and say that based on our studies, these behave better or worse or they can benefit from the following treatments,” Hattab said.

    Also at the July 8 UofL symposium, Michael Prados, M.D., co-project leader of the Pacific Pediatric Neuro-Oncology Consortium, will discuss current research in the area of precision-based therapies for patients with recurrent glioblastomas.

    JGBCC Neuro-oncology Symposium – “Management of Primary Glioma in Adults,” July 8, 2016

    Introduction and overview of primary glioma – Eric Burton, M.D.,assistant professor in the UofL Department of Neurology and director of neuro-oncology at JGBCC.

    Surgical intervention for primary gliomaRaymond Sawaya, M.D., chair and professor of the Department of Neurosurgery at the University of Texas MD Anderson Cancer Center in Houston. Sawaya’s presentation will cover the advantages of radical surgery for primary brain tumors and the technological advances that have allowed such surgeries with reduced morbidity.

    Radiation oncology for primary gliomaShiao Woo, M.D., chair and professor in the UofL Department of Radiation Oncology, professor in the UofL Department of Pediatrics and the Kosair Children’s Hospital/Norton Healthcare Chair in Pediatric Oncology.

    Chemotherapy and clinical trials for adult glioma –Michael Prados, M.D., Charles B Wilson Chair in Neurosurgery and professor emeritus at the University of California San Francisco. Prados will discuss research in the area of precision-based therapies for patients with recurrent glioblastomas.

    Molecular markers for adult gliomaKenneth Aldape, M.D., senior scientist and director of MacFeeters-Hamilton Brain Tumor Centre at Toronto General Hospital and professor in the Department of Laboratory Medicine and Pathobiology at the University of Toronto.

     

    The symposium is co-hosted by the UofL Department of Neurology and the James Graham Brown Cancer Center, a part of KentuckyOne Health. Registration begins at 7:15 a.m. on Friday, July 8, at the Kosair Charities Clinical and Translational Research Building, 505 South Hancock Street on the University of Louisville Health Sciences Campus.

    Continuing education credit is available for health care providers. The event is free for UofL-affiliated providers, $15 for nurses and $20 for all others. For additional information, visit the conference website or contact Emily Rollins at emily.rollins@louisvilleneuroscience.com.

    Hillview supports the James Graham Brown Cancer Center

    Hillview supports the James Graham Brown Cancer Center

    Richard Luce Jr. of Hillview presented a check for $1,800 to Dr. Donald Miller, director of the James Graham Brown Cancer Center at the University of Louisville, at the Hillview City Council meeting held June 20. The donation resulted from the proceeds of the Hillview Cancer Awareness Show, organized by Luce and featuring a model train show, a car, truck and model car show and an arts and crafts show, held May 21 at the Hillview Community Center. Luce organized the event in memory of his father, Richard Luce Sr., a model train enthusiast who died from cancer in 2013. “Since my father’s passing, I have striven to improve cancer awareness,” Luce said. “I am motivated to honor the memory of my father and to hopefully prevent others from enduring the pain of losing a loved one to cancer.” Plans are already underway for the 2017 show, he said. Photos from the check presentation can be viewed here.

    UofL leads first research team to identify AF1q protein associated with multiple myeloma, extramedullary disease

    UofL leads first research team to identify AF1q protein associated with multiple myeloma, extramedullary disease

    William Tse, M.D.

    A group of researchers from the University of Louisville, Japan and Austria is the first to identify a protein, AF1q, associated with multiple myeloma and a condition that occurs in approximately one-fourth of very aggressive multiple myeloma, extramedullary disease or EMD.

    The group will present their findings at the European Hematology Association’s 21st Congress, June 10-12, in Copenhagen, Denmark. Their presentation is entitled “High expression of AF1q is an adverse prognostic factor and a prediction marker of extramedullary disease in multiple myeloma.”

    William Tse, M.D., the Marion F. Beard Endowed Chair in Hematology and chief of the Division of Blood and Bone Marrow Transplantation at UofL, was senior investigator on the project, working with researchers in Tokyo and Vienna.

    Multiple myeloma is one of four types of myeloma and the most prevalent. It is a form of blood cancer that develops in the bone marrow. In multiple myeloma, normal plasma cells transform into malignant myeloma cells and produce large quantities of toxic abnormal immunoglobulin called monoclonal protein that can damage multiple organs. The monoclonal protein produced by the myeloma cells interferes with normal blood cell production.

    The American Cancer Society estimates that 30,330 new cases of multiple myeloma will occur in the United States in 2016 and about 12,600 people will die from it.

    Approximately 25 percent of patients with multiple myeloma also simultaneously develop extramedullary disease. This disease occurs when the myeloma cells form tumors outside of the bone marrow in the soft tissues or organs of the body. The prognosis of myeloma patients with EMD behaves like other metastatic cancers and is extremely poor because its clinical course is veryaggressive, Tse said.

    “We know that multiple myeloma with EMD involvement has an extremely poor outcome,” Tse said. “However, not much is known about the mechanism in which EMD progresses.”

    The group looked at an oncogene, AF1q discovered in Tse’s lab, which is expressed in hematological cancer cells and is known to be related to multiple myeloma. Its presence indicates a poor prognosis for the patient.

    Tse and the team analyzed the degree of expression of AF1q in 117 patients with multiple myeloma. They found that EMD was present in 25 percent of patients with a low AF1q expression and in 44.7 percent of patients with a high AF1q expression.

    “We found that the incidence of EMD was significantly higher in patients with high expression of AF1q than those with low expression,” Tse said. “The significance of this finding gives us a tentative approach to target this marker and could lead to new therapies for this subtype of myeloma.”

    Tse’s research team included Drs. Shotaro Hagiwara, the lead author and chief of hematology, and Sohtaro Mine of the National Center for Global Health and Medicine in Tokyo, Ana-Iris Schiefer of the Medical University of Vienna and Lukas Kenner of the Ludwig Boltzmann Institute for Cancer Research and Medical University of Vienna. The study patient cohort was organized by Hagiwara.

    Tse practices with University of Louisville Physicians-Medical Oncology/Hematology and with UofL’s James Graham Brown Cancer Center, a part of KentuckyOne Health.

    Encounter of a lifetime: John Pierce Wise Sr., Ph.D., met a blue whale for the first time in 18 years of marine mammal research

    He shares the experience and video of the event. >>NOTE: Wise will be the featured speaker at Beer with a Scientist, June 15, 8 p.m. at Against the Grain Brewery<<
    Encounter of a lifetime:  John Pierce Wise Sr., Ph.D., met a blue whale for the first time in 18 years of marine mammal research

    John P. Wise. and research team in the Sea of Cortez

    In April, John Pierce Wise Sr., Ph.D., spent two weeks on a lab-equipped sailboat in the Sea of Cortez collecting tissue samples from free-ranging whales to be tested for chromium, mercury, silver and other toxic metals. He began this research in 1998, and since that time, has embarked on more than two dozen marine research expeditions. This spring’s trip included an experience Wise had hoped for since before he began his research:  His team encountered a blue whale.

     

    When I started, and back even further, the whale I most wanted to see and study was the blue whale. Yet, try as I might, blue whales always seemed just out of my reach. … each time I went near the sea, be it on boat or land, I hoped I would see one of these magnificent creatures.

    Today was finally the day.

    -- John Pierce Wise Sr., Blog post, April 6, 2016

     

    A professor in the UofL School of Medicine’s Department of Pharmacology and Toxicology, Wise is a leading authority on metal-induced cancer development. He studies the cellular and molecular mechanisms of cancer and investigates the health impacts of chemicals in the environment, comparing their effects in humans with wildlife such as whales, sea turtles and alligators. Through this research, he hopes to better understand whether these pollutants cause DNA damage and cancer in marine life and in humans.

    During this trip, Wise and his team of researchers obtained skin and blubber samples from 29 whales of seven different species in the Sea of Cortez, which lies between the Baja peninsula and the mainland of Mexico, emptying into the Pacific Ocean. On this project, Wise is collaborating with Sea Shepherd Conservation Society and Jorge Urbán Ramírez, PhD, at the Universidad Autónoma de Baja California Sur in Mexico. Wise’s son, John Jr., (Johnny) a graduate student in toxicology at Purdue University, and other team members used a crossbow to shoot a small dart into the whales’ skin from the vessel to obtain thimble-sized tissue biopsies without disrupting the animals’ activity. These crossbow handlers are known as biopsiers.

    Following is Wise’s blog describing the encounter with the blue whale –

     

    Wednesday, April 6, 2016 – Day 5 at Sea

    I started developing my whale research in 1998. Hard to believe 18 years have passed as those first days seem like yesterday. I’ve worked on many species from whales to sea lions to sea otters to polar bears. Shoot even humans are considered marine mammals for that matter and we work on them too. But going back to when I started, and then back even further, the whale I most wanted to see and study was the blue whale. Yet, try as I might – blue whales always seemed just out of my reach. We worked on blue whale cells when a colleague gave me a sample. Still, each time I went near the sea, be it on boat or land, I hoped I would see one of these magnificent creatures.

    Today was finally the day.

    The day started with a couple of pods of short finned pilot whales – very cute whales travelling in a small group. We managed three biopsies of them and it seemed liked it was going to be an exciting day. But as sea research days often go, the day quickly settled into a quiet routine of changing watch shifts and the hum of the engine churning away. There was nothing to see and all was quiet. A bird flew by – it was a masked booby – but not much was going on. The team carried out its duties with focus and efficiency, but a sense of no further sampling for the day started to set in.

    Late in the afternoon as the light was fading, several of us were talking in the pilot house. Suddenly, Johnny bolted up and yelled, “whale blow, 9 o’clock.” He ran to the bow and we yelled up to Mark on the mast. Soon Johnny spotted a tail fluke. That left three possibilities – sperm whale, humpback or blue whale. Each has a distinctive shape to their tail. Johnny came into the pilot house and described the fluke. It was not something he had seen before. He has biopsied hundreds of sperm whales and dozens of humpbacks – so I knew then this whale had to be a blue whale. The question was could we get near it and biopsy it?

    To be clear, all whales have a tail fluke. It’s just that not all whales lift their tail flukes out of the water when they dive. Thus, with other whales you simply cannot see their tail flukes in the air. But sperm whales, humpback whales and blue whales frequently raise their tail flukes, almost in a gesture of waving ‘goodbye’ as they dive down deep.

    The team took a collective breath and renewed efforts to find this whale. Everyone wanted to see this magnificent whale that grows to be the biggest animal alive on earth.

    With Oona at the helm, Mark in the crow’s nest, Mike on the rigging and Johnny, Rick, Carlos and me in the foredeck, we pressed on with our search. Closer we crept forward. Closer. Closer. We would have these anxious periods between the whale’s dives, wondering where it might surface. Yet, it stayed just ahead of us. Finally, it was in sight. Carlos pointed out that we should look for the blue water – something about the whale’s coloration creates a bluish glow of a reflection in the water. The glow is why the blue whale is called a “blue” whale.

    Watch a video of the encounter.

    Mark called in the position from above. We all scanned the water for the blue glow. There it was, quite close!!! But just a tad too far for a biopsy. The whale dove and we all marveled at the sight. We kept search, only now it was harder, for the whale had been right next to us. Before, it was in front in the distance. Where did it go? Where would it surface? We slowed our speed and looked.

    Generally, I stay out of the foredeck in the pilot house and let the team work, but this whale was a blue whale and I had waited a long time to see a blue whale. This time, I moved right into the bowsprit with the biopsiers to see the whale up close. Everyone understood. Now, we just had to find the whale.

    Suddenly, the whale surfaced right behind the boat! Oona turned us around as the whale dove. We searched for the blue glow. Carlos starting yelling, “It’s right there! Right there!”

    When someone yells like that, the whale is so close they cannot express in words exactly where it is. We all looked down and sure enough, there was the whale in all its fantastic blue glow – right under us in the bow. What a breathtaking and awesome sight!

    Only problem was the whale was close in and perpendicular to the boat. The biopsiers were at the wrong angle. A sample would be exceptionally difficult. But, there was an odd wrinkle to the biopsiers’ positions. Normally, they are next to each other, but now I was in the bowsprit between them, which created more space. Johnny was the furthest in the bowsprit and he had no angle for a shot. Rick, however, leaned way over the rail and released his arrow!  It hit! He had just enough of an angle to take a perfect biopsy! We recovered the arrow and we had done it! Our first blue whale biopsy. The team was abuzz with excitement.

    The light was low as the sun was setting and it was overcast. We called it a day and shared our stories of our individual thrill from this magnificent whale. We are up to 16 whales biopsied. It’s been a success so far.

    John


    Whale of a tale: How marine mammal research informs us about global pollution at Beer with a Scientist, June 15

    Whale of a tale:  How marine mammal research informs us about global pollution at Beer with a Scientist, June 15

    John Pierce Wise Sr., Ph.D.

    Obtaining and studying tissue samples from hundreds of whales around the world has been a mission and a passion for John Pierce Wise Sr., Ph.D. for the past 18 years.

    A professor in the Department of Pharmacology and Toxicology at the University of Louisville, Wise is a leading authority on metal-induced cancer development. He studies the mechanisms of cancer and investigates the health impacts of chemicals and toxic metals in the environment, comparing their effects in humans with whales, sea turtles, alligators and other wildlife. Wise has conducted more than two dozen marine research expeditions, including three in the Gulf of Mexico following the explosion of the Deepwater Horizon oil well. In April, his team collected tissue samples from free-ranging whales in the Sea of Cortez. Read more about this trip, including a video of his first encounter with a majestic blue whale, at http://uoflnews.com/section/science-and-tech/encounter-of-a-lifetime-uofl-researcher-finally-meets-a-blue-whale/.

    At this month’s Beer with a Scientist, Wise will share his experiences on the water and explain how his research, funded by the U.S. Army, NIH, NASA, NOAA and other sources, is improving our understanding of the effects of environmental pollutants in marine life and in humans.

    The program begins at 8 p.m. on Wednesday, June 15 at Against the Grain Brewery, 401 E. Main St. A 30-minute presentation will be followed by an informal Q&A session.

    The Beer with a Scientist program began in 2014 and is the brainchild of UofL cancer researcher Levi Beverly, Ph.D. Once a month, the public is invited to enjoy exactly what the title promises:  beer and science.

    Admission is free. Purchase of beer, other beverages or menu items is not required but is encouraged.

    Organizers add that they also encourage Beer with a Scientist patrons to drink responsibly.

    For more information and to suggest future Beer with a Scientist topics, follow Louisville Underground Science on Facebook.

    Lung cancer breath ‘signature’ presents promise for earlier diagnosis

    UofL researchers’ analysis of breath samples could lead way to increased survival
    Lung cancer breath ‘signature’ presents promise for earlier diagnosis

    The balloon device and microchip used by the researchers are shown.

    A single breath may be all it takes to identify the return of lung cancer after surgery, according to a study authored by University of Louisville Researchers and posted online today by The Annals of Thoracic Surgery.

    Exhaled breath contains thousands of volatile organic compounds (VOCs) that vary in composition and pattern depending on a person’s health status. A subset of four VOCs—called carbonyl compounds because of their carbon base—have been discovered in the exhaled breath of lung cancer patients. Being able to identify this lung cancer “signature” through a simple breath test has emerged as one of the most promising ways to diagnose the disease. Now the test is being used to monitor for disease recurrence.

    Erin M. Schumer, M.D., of the Department of Surgery, Victor van Berkel, M.D., Ph.D., of the Department of Cardiovascular and Thoracic Surgery and colleagues from the University of Louisville analyzed breath samples collected before and after surgery from 31 lung cancer patients and compared their carbonyl VOCs levels with samples from 187 healthy patients.

    The researchers found a significant decrease in overall carbonyl VOC levels following surgery; in fact, three of the four carbonyl VOCs normalized after surgery, matching levels in the control group.

    “The rapid normalization of almost all of the four compounds after surgery provides strong evidence that they are directly produced by the tumor environment,” Schumer said. “This study confirms that the technology is accurate.”

    Lung cancer is the leading cause of cancer death. The American Cancer Society estimates that more than 224,000 Americans will be diagnosed with lung cancer this year, and more than 158,000 lung cancer patients will die—that translates to 433 lung cancer deaths per day in the United States.

    Schumer said those grim statistics underscore the need for early detection, “We hope that breath analysis will allow us to diagnose patients with primary or recurrent lung cancer long before they suffer from symptoms, when we have more options for treating them, giving them the best chance for cure.”

    Currently, lung cancer patients are followed after surgery with chest computed tomography (CT) scans, which can be inconvenient, expensive, and expose the patient to radiation. “We hope that the breath analysis can serve as the primary screening tool for cancer recurrence and a CT scan ordered only if the breath test suggests that there has been a change,” van Berkel said.

    How the breath test works

    The process of breath analysis is relatively simple. The patient blows a single breath into a specialized balloon. The balloon is then connected to a pump that pulls the breath over a small microchip that is smaller in size than a quarter, trapping the chemicals. The microchip is sent to the lab, where the chemicals are analyzed within hours. Breath collection can be performed in the doctor’s office.

    The pump is reusable; the balloon, microchip and lab test together cost around $20, all supporting the increasing acceptance of breath tests as a cost-effective, easy-to-perform, non-invasive and rapid option for the diagnosis of lung cancer.

    “The great potential with breath analysis is detecting lung cancer at any point, both as a primary screening tool and to follow patients after disease has been treated,” van Berkel said. “The technology is pretty robust. Our next step is getting approval from the FDA.”

     

    Susan Galandiuk, M.D., named editor-in-chief of prestigious scientific journal

    UofL professor of surgery will lead "Diseases of the Colon & Rectum" and move the journal to Louisville
    Susan Galandiuk, M.D., named editor-in-chief of prestigious scientific journal

    Susan Galandiuk, M.D.

    Susan Galandiuk, M.D., professor in the Department of Surgery at the University of Louisville, has been named editor-in-chief of Diseases of the Colon & Rectum, the scientific journal of the American Society of Colon and Rectal Surgeons (ASCRS).

    Galandiuk, director of the Price Institute of Surgical Research at UofL and program director for the Section of Colon and Rectal Surgery, will replace editor-in-chief Robert Madoff, effective January 1, 2017. She will serve a five-year term with a five-year renewal option.

    “It is particularly appropriate that Dr. Galandiuk has been appointed as editor-in-chief of the world’s premier journal in the specialty of colorectal surgery – Diseases of the Colon & Rectum – since her predecessor at the University of Louisville, Dr. Joseph McDowell Mathews, founded this specialty in the United States over a century ago. It is a great honor and we are very proud of Dr. Galandiuk’s achievements,” said Kelly McMasters, M.D., Ph.D., chair of the UofL Department of Surgery.

    Diseases of the Colon & Rectum ranks in the top 14 percent of all peer-reviewed surgery journals. It is mailed to the 3,300 members of ASCRS and also is available online. Editors-in-chief must show a record of significant scholarly achievement, editorial skills and an understanding of the international community of scholars and practitioners.

    Galandiuk has published 150 peer-reviewed articles, 47 book chapters and three books (two at press). Previously, she was associate editor and section editor of Digestive Surgery and has served on editorial boards of Mayo Clinic Proceedings, Annals of Surgery, British Journal of Surgery and others. Galandiuk has served in numerous leadership, review and advisory positions at the local, state, national and international levels, as well as for the United States Food and Drug Administration and National Institutes of Health. She is an alumna of the Executive Leadership in Academic Medicine Program (ELAM), and is recognized among America’s Top Doctors, America’s Top Cancer Doctors and America’s Most Compassionate Doctors.

    In preparation for assuming the duties as editor of Diseases of the Colon & Rectum, Galandiuk is serving as co-editor of the journal. Once she assumes her role as editor, the publication’s editorial office will move from Minnesota to Louisville.

     

    May 31, 2016

    National AARP, Area Agencies on Aging leaders featured at optimal aging conference, June 12-14

    Keynote speakers announced; CEUs, free lecture series offered
    National AARP, Area Agencies on Aging leaders featured at optimal aging conference, June 12-14

    A national vice president of AARP, the CEO of the National Association of Area Agencies on Aging and a University of Louisville Emeritus Geriatrician have been tapped as keynote speakers for The Optimal Aging Conference. The event, hosted by UofL’s Institute for Sustainable Health & Optimal Aging and the Kentucky Association for Gerontology (KAG), will be held June 12-14 at the historic Brown Hotel, 335 W. Broadway.

    Speakers and their addresses are:

    • Barbara Shipley, Senior Vice President of Brand Integration, AARP
      Disrupt Aging: Unlocking the Age Disruptor in All of Us
    • Sandy Markwood, CEO, National Association of Area Agencies on Aging
      Valuing and Supporting People as They Age: The Aging Networks’ Role in Supporting Optimal Aging
    • James O’Brien, M.D., Emeritus Geriatrician, University of Louisville
      Caring for Older Adults: Lessons Learned

    The conference has a variety of options for people interested in revolutionizing the way aging is constructed in our community, said Anna Faul, Ph.D., executive director of the institute. “The Optimal Aging Conference is an exciting opportunity for all individuals dedicated to the belief that aging is an opportunity,” Faul said. “This conference is unique in that we have a variety of professional and academic perspectives present. It is through this sharing of all our perspectives that we will be moving together towards an aging revolution.”

    This is the inaugural conference to be co-hosted by the institute and KAG. “This inaugural year of the Optimal Aging Conference will premiere the power of merging resources to create something even greater than what existed before,” Barbara Gordon, KAG president, said. “Stemming from our long-standing annual conference and the institute’s symposium, the partnership of these two organizations results in an exceptional event that promises to be a coveted learning opportunity for persons in the field of aging the world over.”

    The conference will conclude the afternoon of June 14 with the Smock Lecture Series, featuring five 1-hour presentations. This concluding lecture series is free and open to all conference participants as well as the general public.

    CEU credits are available for physicians, social workers, nurses and other health care professionals. There also are several pre-conference CEU offerings including Social Work Ethics (social work), Domestic Violence (social work) and Assessing and Managing Suicide Risk, a required CEU for social workers, licensed marriage and family therapists, occupational therapists, psychologists and certified alcohol and drug counselors. Information about CEU offerings is found on the conference website.

    Cost to attend is $110 person for students, medical residents and senior citizens age 65 and older; $250 for KAG members; and $270 for other academic and other professional staff. To register, go to the conference website.

    About Barbara Shipley

    Barbara Shipley brings more than 25 years of experience in branding, marketing and strategic communications to her role as senior vice president of brand integration for AARP.  She joined AARP in 2006 to help build and develop the revitalized AARP brand platform and now leads the brand integration efforts for AARP, from the Foundation and AARP Services to the association and its 53 state offices. Prior to joining AARP, she managed the Washington office of public relations firm Ruder Finn and spent more than a decade in various leadership roles with Fleishman Hillard Inc, one of the world’s largest strategic communications firms.  A native New Yorker, Shipley is a graduate of American University and lives in McLean, Va., with her husband and two children.

    About Sandy Markwood

    Chief Executive Officer Sandy Markwood of the National Association for Area Agencies on Aging (n4a) has more than 30 years’ experience in developing aging, health, human services, housing and transportation programs in counties and cities across the nation. Prior to coming to n4A in January 2002, Sandy served as the deputy director of county services at the National Association of Counties. As CEO, Sandy is responsible for n4a’s overall management, setting strategic direction and overseeing the implementation of all policy, grassroots advocacy, membership and program initiatives. She also leads n4a’s fundraising efforts and engages corporate sponsors to support initiatives, including an aging awards/best practices program and the Leadership Institute for Area Agency on Aging. Sandy holds bachelor’s and master’s degrees from the University of Virginia.

    About James O’Brien, M.D.

    James O’Brien received his medical degrees at University College, Dublin, and completed a residency in family medicine at Saginaw Cooperative Hospitals in affiliation with Michigan State University and a fellowship in geriatrics at Duke University Medical Center. He spent 19 years on the faculty at MSU where he initiated the first geriatric fellowship. He assumed the Margaret Dorward Smock Endowed Chair in Geriatrics at UofL in 1996.  He became acting chair of Family Medicine in 2002 and chair of the renamed Department of Family and Geriatric Medicine in 2003, a position he held until 2015 when he was named Emeritus Geriatrician. He has been named a “Best Doctor in Louisville” by Louisville Magazine and is a past recipient of ElderServe’s Champion of Aging Award.

    Four with ties to UofL named MOSAIC Award winners

    Jewish Family & Career Services annual honor recognizes immigrant success

    Two current University of Louisville faculty members, the daughter of a faculty member and a former faculty member are among the 2016 recipients of an annual award that honors the contributions made by immigrants to the Louisville community.

    The MOSAIC Awards, presented by Jewish Family & Cultural Services, will be presented Thursday, May 26, at the Marriott Louisville Downtown Hotel, 280 W. Jefferson St. The event kicks off at 5 p.m. with a reception showcasing local entrepreneurial talent followed by dinner and presentation of the awards.

    The “MOSAIC” name represents “Multicultural Opportunities for Success & Achievement In our Community,” and the annual awards dinner is a fundraising event to benefit JFCS. Every year since 2006, JFCS has honored new or first-generation immigrants and refugees who are making a significant contribution in their professions and in the community.

    This year’s honorees are Dr. Emma Birks and Dr. Riaan van Zyl, both current University of Louisville faculty; Oksana Masters, the daughter of UofL faculty member Dr. Gay Masters; former faculty member Thangam “Sam” Rangaswamy;  and Dr. Manuel Grimaldi,

    “JFCS was founded to assist newcomers to Louisville, and this event honors its original mission,” Judy Freundlich Tiell, JFCS executive director, said. “To date, the event has recognized 52 international Americans who make our community a richer and more interesting city, creating a mosaic of many colors and perspectives.”

    Tickets to the event are $125 per person, and table sponsorships begin at $1,500. For reservations, contact Beverly Bromley, JFCS director of development, at 502-452-6341, ext. 223, or bbromley@jfcslouisville.org.

    About the honorees
    Emma Birks, M.D., Ph.D., is from Great Britain and is a professor of medicine and director of the Heart Failure, Transplantation and Mechanical Circulatory Support program in the Division of Cardiovascular Medicine at the University of Louisville. She practices with University of Louisville Physicians-Cardiovascular Medicine and is affiliated with Jewish Hospital, a part of Kentucky OneHealth.

    Birks developed a myocardial recovery program and the burgeoning Ventricular Assist Devices and Transplant programs in Louisville. She currently teaches cardiology fellows and residents and started a heart failure fellowship program.

    Birks works closely with cardiothoracic surgery and biomedical engineering and is involved in translational research studies. Her research focuses on inducing myocardial recovery and on the underling molecular mechanisms in recovery with the goal of reversing heart failure.

    Originally from South Africa, Riaan van Zyl, Ph.D., is professor and associate dean for research in the Kent School of Social Work at UofL. His leadership and involvement in progressive social matters led to solutions that work, such as the first alcohol safety program in South Africa’s criminal justice system and programs for those with epilepsy.

    He founded the South African Association of Mediators, facilitated the national aging policy for the National Department of Welfare and united all of South Africa’s schools of social work in a transformation process that developed high educational standards, and helped to reform the prison systems.

    Van Zyl continues work in the area of prevention of HIV/AIDS in Africa. After joining the UofL faculty in 2000, he set about creating a new environment for research, building relationships with the community and creating a collaborative environment where faculty work with each other to solve community problems. He also has positioned the school to be one of the fastest growing in the country in terms of federal research dollars.

    Oksana Masters from Ukraine was born with several radiation-induced birth defects. She was abandoned and lived in orphanages until she was seven. She endured surgeries, amputations, hunger and physical abuse, something no child should have to endure; yet she survived. She was adopted by M. Gay Masters, Ph.D., who is an assistant professor in the UofL Department of Otolaryngology-Head & Neck Surgery and Communicative Disorders and practices with UofL Physicians-Speech-Language Pathology

    Oksana Masters and her partner, Rob Jones, earned a bronze medal in trunk & arms rowing at the 2012 Paralympics. This was the first medal for the USA in this category. She was then named US Rowing Female Athlete of the Year in 2012, first time ever for a para-rower.

    In 2014, after one full season on sit-skis, Oksana earned silver and bronze medals in Nordic Cross Country at the 2014 Paralympics. In 2015, during her next season on snow, she earned cross country World Championship medals and was World Cup Leader. She also earned a bronze medal at the Paracycling World Championships in 2015 as well as numerous medals in World Cup competitions in cross country, biathlon and handcycling. She is currently working to qualify for her third Paralympic.

    Thangam “Sam” Rangaswamy, Ph.D., is from India and is the president and principal engineer of Rangaswany & Associates Inc., which he founded. He has taught concrete courses at the UofL Speed School of Engineering.

    He is the founder of the Structural Engineering Association of Kentucky and served as its president, director and secretary. He has also served as Kentucky Minority Business Development Council treasurer, secretary and board member.

    Rangaswany was given the U.S. Small Business Administration Person of the Year Award in 1985. He is a registered engineer in nine states and has received many national structural engineering and concrete masonry design awards.

    He is currently serving on the Parking Authority of River City Board (PARC) and the Kentucky Board of Medical Licensure. Rangaswamy was a founding trustee involved in the building and opening of the Hindu Temple of Kentucky and organized the India Community Foundation of Louisville.

    The only honoree not associated with UofL, Manuel Grimaldi, M.D., came from Spain to the United States in order to be certified in internal medicine (1976) and medical oncology (1977). He joined the practice of Drs. Beard, Fuller and Dobbs currently known as CBC in 1977.

    He has won numerous accolades, including the American Cancer Society Physician of the Year Award in 2010 and The Leukemia and Lymphoma Society Award. Upon retirement, he became a volunteer through the Greater Louisville Medical Society, donating his time, knowledge and service in medical missionary trips to Nicaragua and Belize.

    Grimaldi has traveled to Nicaragua numerous times with Hand to Hand Ministries, visiting hospitals and clinics where he provided families, women and children with routine health care that would otherwise be unavailable to them. He raised funds to build homes in Belize and also served as a medical missionary for homebound families living with HIV.

     

     

    Two UofL medical students receive Fulbright-Fogarty Fellowships for research in sub-Saharan Africa

    UofL is first medical school with two awardees in the same year
    Two UofL medical students receive Fulbright-Fogarty Fellowships for research in sub-Saharan Africa

    Mackenzie Flynn and Jessica Eaton

    Jessica Eaton and Mackenzie Flynn, students in the University of Louisville School of Medicine, will delay their fourth year of medical school to spend nine months conducting medical research in Malawi and Kenya. Thanks to Fulbright-Fogarty Fellowships in Public Health for 2016-2017, Eaton plans to research the causes and assess the outcomes of brain and spinal cord injuries in Lilongwe, Malawi, and Flynn will work with pregnant HIV-positive women in Nairobi, Kenya to determine whether text messaging can increase compliance with treatments to prevent HIV transmission to their infants.

    Fulbright-Fogarty Fellowships are offered for students enrolled in medical school or a graduate program in public health through a partnership between the U.S. government’s Fulbright international study program and the Fogarty International Center of the National Institutes of Health. This is the first time two students in the same medical school have received Fulbright-Fogarty fellowships in a single year.

    Eaton and Flynn have cultivated their interest in global health through participation in the Distinction in Global Health track (DIGH) at UofL, a supplemental curriculum for students in the school of medicine that introduces students to aspects of global health through clinical, social, political and epidemiological study.

    “The Fulbright-Fogarty Fellowship is a great opportunity to participate in real-world experience in global health research,” said Bethany Hodge, M.D., M.P.H., director of the DIGH track and the UofL School of Medicine’s Global Education Office. “These experiences will take their academic skills to a higher level and prepare them for careers in global health.”

    As part of her research, Eaton will conduct a retrospective review of trauma records to determine the causes of traumatic brain and spinal cord injuries (TBI/SCI) as well as their treatment outcomes. In addition, she will conduct research to identify the best predictors of surgical outcomes in TBI/SCI patients using the patient’s signs and symptoms to determine a surgical plan since the hospital lacks advanced imaging facilities such as CT or MRI. Eaton will conduct her research at Kamuzu Central Hospital (KCH) in Lilongwe, Malawi under the guidance of Anthony Charles, M.D., M.P.H., and other faculty with the UNC Malawi Surgical Initiative. She will use the surgical initiative’s trauma and surgical registry, one of the largest such registries in sub-Saharan Africa.

    “As a medical student planning to pursue neurosurgery and dreaming of practicing overseas in the places where I am most needed, I couldn't have crafted a better learning opportunity for myself,” Eaton said.

    As an undergraduate at UofL, Eaton was one of the inaugural James Graham Brown Fellows. That fellowship provided her with opportunities to travel, which sparked her interest in global health. She plans to enter neurosurgery and incorporate global health into her practice. [Hear Jessica Eaton's interview on UofL Today with Mark Hebert]

    Flynn’s research will focus on preventing mother-to-child HIV transmission. Anti-retroviral therapy (ART) helps increase lifespan and delay progression to AIDS in patients with HIV and is considered key to the prevention of mother-to-child transmission of HIV. Flynn’s project will investigate whether text messages sent to pregnant HIV-positive women will increase ART adherence and prenatal health care visits. She will conduct her research under primary investigator Alison Drake, Ph.D., M.P.H., in collaboration with the Kenya Medical Research Institute in Nairobi and the Kenya Research Program at the University of Washington.

    “This is an excellent opportunity to really understand how medical research can differ from benchwork,” Flynn said. “Epidemiology, clinical trials conducted in an international setting, IRB approval and ethical considerations are all things I want to incorporate into my career in academia and in global health.”

    This year’s fellowship will be the second Fulbright experience for Flynn. After receiving her bachelor’s degree at UofL in 2012, Flynn received a Fulbright English Teaching Assistantship to Sivas, Turkey, where she taught university-level English-speaking courses to college freshmen at Cumhuriet University. Flynn’s work in Kenya will build on experience she had during a medical service trip to Tanzania where she worked in an area with a high prevalence of HIV infections. She hopes to pursue a career in academic medicine and work in international health and research as an ob/gyn. [Hear Mackenzie Flynn's interview on UofL Today with Mark Hebert]

    Hodge said the experience and research training Eaton and Flynn will receive will benefit not only their academic careers, but the other students in the DIGH track once they return to UofL to complete their M.D. program in August of 2017.

    “We talk about global health as an academic discipline and think critically about the gaps in knowledge in this field. We spend a lot of time looking at the literature and thinking about the roles of physicians as researchers, policy-makers and social advocates in global health, in addition to being clinicians,” Hodge said. “I look forward to these students returning after their fellowships because their boots-on-the-ground experience will enrich the discussions we have as a group. Hopefully they will inspire other students to pursue academic work in global health.”

    ###

    About the Fulbright-Fogarty Fellowship in Public Health

    The Fulbright Program, the flagship international educational exchange program sponsored by the U.S. government, has partnered with Fogarty International Center of the U.S. National Institutes of Health to offer Fulbright-Fogarty Fellowships in Public Health. These fellowships grant medical students and graduate students interested in global health the opportunity to conduct research in public health and clinical research in resource-limited settings. Fellows spend nine months in one of nine countries in Sub-Saharan Africa, Asia or South America. The Fulbright-Fogarty program began in 2011.

    Cancer Awareness Show 2016

    Cancer Awareness Show 2016

    Spirits were buoyant despite gloomy skies at the Cancer Awareness Show, held May 21 at Hillview Community Center to benefit the University of Louisville’s James Graham Brown Cancer Center. Volunteer Richard Luce Jr. organized the event that featured a car and truck show, a model car show, a model train show and an arts and crafts show along with a silent auction, music, food, games and more. Proceeds are still being compiled and will be formally presented at an upcoming meeting of the Hillview City Council. To see all the fun from the event, visit our photo gallery.

    Amy Holthouser, M.D., selected for executive leadership program in medical education

    Amy Holthouser, M.D., selected for executive leadership program in medical education

    Amy Holthouser, M.D.

    University of Louisville associate dean for medical education and associate professor of medicine and pediatrics Amy Holthouser, M.D., has been selected as a member of the 2016-2017 class of the Hedwig van Ameringen Executive Leadership in Academic Medicine Program (ELAM). Holthouser is one of only 54 women in the nation selected for the program, and is the 18th UofL faculty member to participate.

    ELAM is a year-long fellowship for women faculty in schools of medicine, dentistry and public health in which they develop professional and personal skills required for leadership and management in health care. More than 900 ELAM alumnae hold leadership positions in institutions around the world.

    Holthouser oversees the design and implementation of the MD program curriculum. She also leads the steering committee for the eQuality Project at UofL, a national pilot initiative to integrate competencies published by the Association of American Medical Colleges (AAMC) related to provision of care for LGBT and DSD individuals into the school of medicine curriculum. Holthouser was a primary investigator on a Robert Wood Johnson Foundation grant to develop a required palliative care educational experience for medical students, and co-investigator on iCOPE, a five-year NIH grant funding the development of an interdisciplinary palliative care curriculum to improve the care of cancer patients.

    Among her 24 teaching awards at the university and school of medicine level, Holthouser has received the American College of Physicians Outstanding Faculty Award and twice won the American Medical Women’s Association Gender Equity Award. The Louisville native is an alumna of the UofL School of Medicine where she also completed her residency training in internal medicine and pediatrics. In addition to her academic duties, Holthouser practices as a pediatric hospitalist at Kosair Children’s Hospital.

    In ELAM’s 21-year history, 17 faculty members from UofL have completed the fellowship. Toni Ganzel, M.D., M.B.A., dean of the UofL School of Medicine, is among UofL’s ELAM alumnae, and Diane Harper, M.D., M.P.H., M.S., chair of the Department of Family and Geriatric Medicine, was part of the 2015-2016 class. A complete list of UofL’s ELAM alumnae is included below.

    Top brain cancer specialists to speak on primary gliomas July 8

    Second annual James Graham Brown Cancer Center Neuro-oncology Symposium
    Top brain cancer specialists to speak on primary gliomas July 8

    Kosair Charities Clinical and Translational Research Building

    Some of North America’s most respected physician researchers in neuro-oncology will share their expertise with physicians and the public at the second annual James Graham Brown Cancer Center Neuro-oncology Symposium on July 8 at the University of Louisville.

    “Management of Primary Glioma in Adults,” co-hosted by the UofL Department of Neurology and the James Graham Brown Cancer Center, a part of KentuckyOne Health, will be Friday, July 8 from 7:15 a.m. to 1 p.m. at the Kosair Charities Clinical and Translational Research Building, 505 South Hancock Street on the University of Louisville Health Sciences Campus.

    Conference director Eric Burton, M.D., assistant professor in the UofL Department of Neurology and director of neuro-oncology at JGBCC, will provide an overview of adult glioma, a tumor that develops in the supportive tissue of the brain. Presenters from MD Anderson Cancer Center, University of California, San Francisco, Toronto General Hospital and the University of Louisville will then address best current practices and future treatment directions for patients with primary gliomas using surgery, radiation and chemotherapy, as well as a discussion of molecular markers in adult glioma.

    “These are some of the most influential and highly respected physician researchers in neuro-oncology and neuropathology,” Burton said. “This is an excellent opportunity for physicians across the region, as well as patients and their families, to learn about the latest developments in the pathology and treatment of brain tumors.”

    In addition to Burton, presenters include:

    Kenneth Aldape, M.D., senior scientist and director of MacFeeters-Hamilton Brain Tumor Centre at Toronto General Hospital and professor in the Department of Laboratory Medicine and Pathobiology at the University of Toronto. Aldape is a neuropathologist with a research interest in primary brain tumors. His work includes the identification of biomarkers in gliomas, characterizing glioma subtypes and identifying clinically relevant molecular alterations in these tumors. In 2014, Aldape received the Guha Award for Excellence in Neuro-Oncology Research from the Society for Neuro-Oncology.

    Michael Prados, M.D., Charles B Wilson Chair in Neurosurgery and professor emeritus at the University of California San Francisco. Prados led the North America Brain Tumor Consortium for 15 years and was co-project leader of the Adult Brain Tumor Consortium until 2014. He formed and is co-project leader of the Pacific Pediatric Neuro-Oncology Consortium, a consortium of 15 major academic centers across the United States, and is co-project leader of a pediatric brain tumor SPORE project at UCSF. Prados has been NIH/NCI funded continuously since 1994 and is a member of the NCI/CTEP Brain Malignancies Steering Committee. In 2014, he was awarded the Victor Levin Award for lifetime clinical research excellence from the Society of Neuro-Oncology.

    Raymond Sawaya, M.D., chair and professor of the Department of Neurosurgery at the University of Texas MD Anderson Cancer Center in Houston. He is director of the Brain Tumor Center at MD Anderson and served as professor and chair of the Department of Neurosurgery at Baylor College of Medicine from 2005-2014. His awards include the Joseph P. Evans Award in Neurosurgery at the University of Cincinnati and the Charles Wilson Award from the National Brain Tumor Society. He is past chairman of the American Association of Neurological Surgeons/Congress of Neurological Surgeons Section on Tumors. Sawaya has particular expertise in primary and metastatic brain tumors and is renowned for his strides in enhancing the accessibility and safety of brain tumor surgery.

    Shiao Woo, M.D., chair and professor in the UofL Department of Radiation Oncology, professor in the UofL Department of Pediatrics and the Kosair Children’s Hospital/Norton Healthcare Chair in Pediatric Oncology. His clinical focus and research is on brain and spine tumors, pediatric cancer and lung cancer. Woo has received Clinical Fellowship Awards from the American Cancer Society, Teacher of the Year Award from the Association of Residents in Radiation Oncology and the Patient Golden Apple Award from the MD Anderson Cancer Center. He also served as president of the MD Anderson Radiation Oncology Gilbert H. Fletcher Society.

    “We have invited speakers with varied areas of expertise with the intention of creating a collaborative environment that will improve the regional standard of care,” Burton said.

    Continuing education credit is available for health care providers. The event is free for UofL-affiliated providers, $15 for nurses and $20 for all others. For additional information, visit the conference website or contact Emily Rollins at emily.rollins@louisvilleneuroscience.com.

    School yard becomes latest urban laboratory in Louisville

    St. Margaret Mary School will be the site of a new green installation by UofL
    School yard becomes latest urban laboratory in Louisville

    These current and projected site photos of the Louisville Green for Good project show how new plantings will provide a green buffer for St. Margaret Mary.

    May 19, 2016

    A local school has joined a landmark health research project headed by the University of Louisville designed to use nature to tackle the health impact of busy city streets.

    St. Margaret Mary School, 7813 Shelbyville Road, is the new site of an experiment designed to use trees and shrubs to create a living filter for roadway air pollution. The project will be a model for metro-wide "greening" projects that use our environment to improve health.

    The Louisville Green for Good project is a collaboration among the Diabetes and Obesity Center at the University of Louisville, The Institute for Healthy Air Water and Soil and the City of Louisville’s Office of Sustainability.

    The current levels of air pollution at the school will be measured and then half of the school’s front yard will be filled with a green buffer of shrubs, deciduous trees and pines. Then the team will measure air pollution levels a second time. The goal is to test the idea that a greener neighborhood is a healthier neighborhood.

    “This project has the potential to improve the health of nearby students and residents for years to come by improving local air quality," said Aruni Bhatnagar, Ph.D., the Smith and Lucille Gibson Chair in Medicine and director of the University of Louisville Diabetes and Obesity Center. “St. Margaret Mary was chosen due to its location which is close to a high traffic roadway. The school also includes a spacious lawn that allows for the addition of foliage, which will act as an air-cleansing barrier between the school and the street.”

    Mayor Greg Fischer said, “I am committed to helping Louisville become a greener and healthier place to live – and, I’m a data guy. So I’m excited that this project will provide the data we need to move forward on our sustainability goals for the city.”

    St. Margaret Mary Principal Wendy Sims said she isexcited about this project for the parish, school and community.

    “In his encyclical letter ‘Laudato Si’,’ Our Holy Father Pope Francis reminds us that ‘we must regain the conviction that we need one another, that we have a shared responsibility for others and for the world, and that being good and decent are worth it...social love moves us to devise larger strategies to halt environmental degradation and to encourage a “culture of care” which permeates all of society’,” Sims said. “This project is a wonderful lesson for our students, faculty, and parents about how to foster such a culture of care, now and for future generations.”

    Air monitoring will start this summer. The trees and shrubs will arrive in October with a second round of air monitoring taking place later this year. Students will participate in the monitoring work.

    In addition to tracking certain pollutants, the project team will collect data on traffic and weather.

    The project includes ecology experts from around the country with deep understanding of air pollution and the power of plants.

    Funding comes from the Funders’ Network for Smart Growth and Livable Communities.

    The research effort is a project of the Funders’ Network for Smart Growth and Livable Communities. The grant was matched with $50,000 from the Owsley Brown Charitable Foundation and $25,000 from an anonymous donor in Louisville. The Institute for Healthy Air, Water, and Soil received the funds and will be managing the project.